Fed. Circ. Urged To Overturn Natera's Cancer Test Patent Win
ArcherDX is asking the Federal Circuit to fully free it from a Delaware federal jury's $19 million verdict for infringing Natera cancer diagnostic patents, saying the district court judge was wrong...To view the full article, register now.
Already a subscriber? Click here to view full article